Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Director | May 26, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,228.707 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 11,680 · Balance 42,228.707 F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 23:32 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 11,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038976 · wk-form4_1780011142.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,228.707 F1 · shares: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. Read SEC document |
| May 11, 2026 Filed May 12, 2026 23:10 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 2,500 | $12.53 | $31,325.00 |
DisclosureSEC source: 0001628280-26-034271 · wk-form4_1778627443.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,548.707 Read SEC document |
| May 08, 2026 Filed May 12, 2026 23:10 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 2,500 | $12.65 | $31,625.00 |
DisclosureSEC source: 0001628280-26-034271 · wk-form4_1778627443.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,048.707 Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 23:05 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 11,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-033185 · wk-form4_1750979094.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,548.707 F1 · shares: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:48 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 6,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-029657 · wk-form4_1719265691.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,380.707 F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:18 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · derivative · entry 4 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,300 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:18 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,753 | $39.46 | $108,633.38 |
DisclosureSEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 3 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,784.707 F1 · price: The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:18 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,300 | $39.41 | $51,233.00 |
DisclosureSEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,537.707 Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:18 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 1,300 | $27.68 | $35,984.00 |
DisclosureSEC source: 0001628280-24-010641 · wk-form4_1710278284.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,837.707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2023 Filed Nov 10, 2023 01:19 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 52.646 | $68.89 | $3,626.78 |
DisclosureSEC source: 0001628280-23-038376 · wk-form4_1699579176.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,537.707 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 21:36 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 39.824 | $89.42 | $3,561.06 |
DisclosureSEC source: 0001628280-23-028942 · wk-form4_1691703382.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,485.061 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| June 15, 2023 Filed Jun 21, 2023 00:31 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 3,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022802 · wk-form4_1687307451.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,445.237 F1 · shares: Represents the right to receive 3,152 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. Read SEC document |
| May 09, 2023 Filed May 11, 2023 21:41 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 13.145 | $87.50 | $1,150.19 |
DisclosureSEC source: 0001628280-23-017663 · wf-form4_168384127527001.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,293.237 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 22:09 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · derivative · entry 3 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 2,200 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 22:09 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,200 | $108.68 | $239,096.00 |
DisclosureSEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,280.092 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 22:09 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 2,200 | $27.68 | $60,896.00 |
DisclosureSEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,480.092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:04 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 9.804 | $114.97 | $1,127.17 |
DisclosureSEC source: 0001628280-23-003050 · wf-form4_167599465954281.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,280.092 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 23:33 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 10.382 | $106.93 | $1,110.15 |
DisclosureSEC source: 0001628280-22-029562 · wf-form4_166812316325297.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,270.288 F1 · shares: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:02 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 7.906 | $138.78 | $1,097.19 |
DisclosureSEC source: 0001104659-22-088741 · tm2223137-6_4seq1.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,259.906 F1 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| June 16, 2022 Filed Jun 22, 2022 01:16 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073171 · tm2219043-5_4seq1.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,252 F1 · shares: Represents the right to receive 1,448 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:41 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-077871 · tm2119051-5_4seq1.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 F1 · shares: Represents the right to receive 669 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Read SEC document |
| June 03, 2021 Filed Jul 1, 2021 01:10 UTC Amendment | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-087804 · tm2121193-1_4aseq1.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,804 F1 · balance_after: On June 7, 2021, the reporting person filed a Form 4 which inadvertently did not reflect the sale of 96 shares of common stock that was previously reported on a Form 4 filed on May 21, 2021. As reported in this amendment, the reporting person beneficially owns 5,804 shares of common stock. Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:19 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 96 | $311.57 | $29,910.72 |
DisclosureSEC source: 0001104659-21-070571 · tm2117278-1_4seq1.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,135 Read SEC document |
| May 19, 2021 Filed May 21, 2021 21:19 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 904 | $310.09 | $280,321.36 |
DisclosureSEC source: 0001104659-21-070571 · tm2117278-1_4seq1.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,231 Read SEC document |
| June 16, 2020 Filed Jun 19, 2020 00:41 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-074833 · tm2022977d6_4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,135 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:26 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001562180-20-004311 · primarydocument.xml · derivative · entry 4 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,500 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, vested and became non-forfeitable on each of the first, second and third anniversaries of the Grant Date subject to the requirements of the Plan and Award Agreement beginning on 04-Feb-2016. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:26 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,500 | $107.77 | $161,655.00 |
DisclosureSEC source: 0001562180-20-004311 · primarydocument.xml · nonDerivative · entry 3 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,436 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $107.79, inclusive. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:26 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,619 | $107.35 | $173,799.65 |
DisclosureSEC source: 0001562180-20-004311 · primarydocument.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.28 to $107.46, inclusive. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:26 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 1,500 | $27.68 | $41,520.00 |
DisclosureSEC source: 0001562180-20-004311 · primarydocument.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 23:09 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 990 | $131.21 | $129,897.90 |
DisclosureSEC source: 0001144204-19-013570 · tv516093_form4.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,055 F2 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.01 to $131.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 23:09 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,010 | $130.64 | $131,946.40 |
DisclosureSEC source: 0001144204-19-013570 · tv516093_form4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,045 F1 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:50 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Options · Derivative | 2,500 | $0.00 Strike: $28.59 | $0.00 |
DisclosureSEC source: 0001144204-19-012827 · tv515786_4.xml · derivative · entry 3 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in three equal annual installments beginning on 2/17/2016. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:50 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,500 | $129.80 | $324,500.00 |
DisclosureSEC source: 0001144204-19-012827 · tv515786_4.xml · nonDerivative · entry 2 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:50 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 2,500 | $28.59 | $71,475.00 |
DisclosureSEC source: 0001144204-19-012827 · tv515786_4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:01 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-010329 · tv514786_4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 23:22 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-007046 · tv485457_form4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,001 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:55 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,639 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010260 · v460095_4.xml · nonDerivative · entry 1 SCHLACKMAN SCOTT · CIK 0001645617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,382 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.